ASTH Astrana Health Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$35.88
· % 处于52周区间
· 高于低点
· 至高点
$18.4352周低点
$51.6052周高点
市值
$1.75B
P/E (TTM)
43.8
EPS (TTM)
$0.82
收入 (TTM)
$3.84B
ASTH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$35.88
市值
$1.75B
P/E (TTM)
43.8
EPS (TTM)
$0.82
收入 (TTM)
$3.84B
股息收益率
0.45%
ROE (TTM)
5.1%
负债/权益 (MRQ)
1.1
52周区间
$18–$52
ASTH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2015年4月27日 | 1-for-10 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$3.18B2021-12-31 → 2025-12-31
EPS$0.462021-12-31 → 2025-12-31
自由现金流$104M2021-12-31 → 2025-12-31
净利率1.1%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ASTH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 43.85年均值 ≈37.1 | ≈37.1 | 22.4 | 估值过高 | |
| P/S | 0.6 | · | 1.1 | 低估 | |
| P/B (市净率) | 2.3 | · | 2.4 | 低估 | |
| EV / EBITDA (企业价值 / EBITDA) | 19.0 | · | 13.9 | 估值过高 | |
| Price / FCF (股价/自由现金流) | 16.8 | · | · | · | |
| Price / Cash Flow (市现率) | 15.3 | · | 14.2 | 低估 | |
| EV / Revenue (市值/营收) | 0.7 | · | · | · | |
| EV / FCF (市值/自由现金流) | 22.6 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ASTH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 2.6%5年均值 ≈5.5% | ≈5.5% | 3.8% | 持平 | |
| 息税折旧摊销前利润率 (TTM) | 4.3%5年均值 ≈6.9% | ≈6.9% | 3.8% | 持平 | |
| 税前利润率 (TTM) | 1.6%5年均值 ≈4.8% | ≈4.8% | 3.0% | 弱 | |
| 净利润率 (TTM) | 1.1%5年均值 ≈2.8% | ≈2.8% | 2.4% | 低于平均水平 | |
| ROA (TTM) | 2.2%5年均值 ≈3.8% | ≈3.8% | 0.70% | 顶尖 | |
| ROE (TTM) | 5.1%5年均值 ≈6.7% | ≈6.7% | 2.4% | 顶尖 | |
| ROIC | 2.6%5年均值 ≈4.5% | ≈4.5% | 3.8% | 低于平均水平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ASTH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 1.15年均值 ≈0.8 | ≈0.8 | 0.2 | 高负债 | |
| 流动比率 (MRQ) | 1.25年均值 ≈1.8 | ≈1.8 | 1.2 | 持平 | |
| Quick Ratio (速动比率) | 1.35年均值 ≈1.2 | ≈1.2 | 1.0 | 流动性强 | |
| 长期负债/股东权益 (MRQ) | 1.15年均值 ≈0.8 | ≈0.8 | 0.3 | 高负债 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ASTH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 56.4%5年均值 ≈43.0% | ≈43.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 40.6%5年均值 ≈35.0% | ≈35.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 35.9% | · | · | · | |
| EPS YoY | -48.9%5年均值 ≈-20.9% | ≈-20.9% | · | · | |
| Net Income YoY (净利润同比增长) | -47.9%5年均值 ≈-19.2% | ≈-19.2% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | -22.6%5年均值 ≈-10.0% | ≈-10.0% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | -14.5% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | -20.8%5年均值 ≈-6.0% | ≈-6.0% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | -9.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ASTH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.85年均值 ≈1.7 | ≈1.7 | 1.2 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 9.8 | · | 9.3 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.1M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
股息收益率0.45%
派息率35.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-28.0%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $0.40 | $0.34 | 16.7% |
| 2026年3月31日 | 五月 13, 2026 | $0.29 | $0.30 | -4.9% |
| 2025年12月31日 | $0.12 | $0.11 | 11.0% | |
| 2025年9月30日 | $0.01 | $0.45 | -97.8% | |
| 2025年6月30日 | $0.19 | $0.37 | -48.7% | |
| 2025年3月31日 | $0.14 | $0.25 | -44.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $774M | $687M | $561M | $520M | $356M | $306M | |
| Cost of Revenue | · | · | · | · | $596M | $539M | $468M | $361M | $273M | $255M | |
| SG&A Expense | $217M | $154M | $113M | $78M | $62M | $49M | $41M | $43M | $26M | $21M | |
| Operating Expenses | $3.10B | $1.95B | $1.30B | $1.04B | $676M | $607M | $528M | $431M | $321M | $294M | |
| Operating Income | $79M | $89M | $85M | $104M | $98M | $81M | $32M | $88M | $35M | $12M | |
| Interest Expense | · | · | $16M | $8M | $5M | $9M | $5M | $561.0K | $79.7K | $61.6K | |
| Interest Income | $12M | $15M | $14M | $2M | $2M | $3M | $2M | $1M | $1M | $504.7K | |
| Other Non-op | $-3M | $5M | $6M | $4M | $-4M | $1M | $3M | $2M | $168.1K | $233.7K | |
| Pretax Income | $40M | $81M | $90M | $87M | $78M | $178M | $26M | $83M | $50M | $19M | |
| Income Tax | $16M | $31M | $32M | $41M | $32M | $56M | $8M | $22M | $4M | $9M | |
| Net Income | $22M | $43M | $61M | $45M | $69M | $38M | $14M | $11M | $26M | $11M | |
| EPS (Basic) | $0.46 | $0.91 | $1.30 | $1.00 | $1.57 | $1.03 | $0.41 | $0.33 | $1.01 | $0.46 | |
| EPS (Diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | $0.41 | |
| Shares (Basic) | 49,075,727 | 47,597,295 | 46,553,256 | 44,971,143 | 43,828,664 | 36,527,672 | 34,708,429 | 32,893,940 | 25,525,786 | 24,673,081 | |
| Shares (Diluted) | 49,369,685 | 47,974,334 | 46,943,140 | 45,602,415 | 45,403,085 | 37,448,430 | 36,403,279 | 37,914,886 | 28,661,735 | 27,970,431 | |
| EBITDA | $124M | $117M | $102M | $122M | $116M | $99M | $51M | $108M | $54M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $429M | $288M | $294M | $288M | $233M | $193M | $103M | $107M | $100M | $55M | |
| Short-term Investments | · | $2M | $2M | $6M | $53M | $68M | $117M | $1M | $1M | $1M | |
| Receivables | $374M | $276M | · | $50M | $11M | $7M | $11M | $8M | $8M | $22M | |
| Prepaid Expense | $26M | $25M | $17M | $15M | $19M | $17M | $10M | $7M | $5M | $2M | |
| Current Assets | $863M | $638M | $462M | $428M | $404M | $339M | $329M | $173M | $144M | $81M | |
| PP&E (Net) | $57M | $14M | · | · | · | · | · | $13M | $14M | $10M | |
| PP&E (Gross) | $87M | $39M | · | · | · | · | · | $27M | $26M | $19M | |
| Accum. Depreciation | $30M | $25M | · | · | · | · | · | $14M | $12M | $8M | |
| Goodwill | $865M | $419M | $279M | $269M | $246M | $232M | $239M | $186M | $190M | $103M | |
| Intangibles | $271M | $118M | $72M | $77M | $83M | $87M | $103M | $87M | $104M | $108M | |
| Other Non-current Assets | $25M | $17M | $2M | $5M | $6M | $19M | $2M | $1M | $2M | $2M | |
| Total Assets | $2.22B | $1.35B | $933M | $966M | $867M | $817M | $729M | $513M | $491M | $350M | |
| Accounts Payable | $196M | $106M | $60M | $50M | $44M | $36M | $27M | $4M | $4M | $1M | |
| Current Liabilities | $615M | $366M | $219M | $149M | $115M | $115M | $105M | $72M | $110M | $51M | |
| Capital Leases | $32M | $31M | $36M | $20M | $13M | $16M | $11M | $517.3K | $619.0K | $0 | |
| Deferred Tax | $5M | $5M | $4M | $14M | $30M | $11M | $18M | $20M | · | · | |
| Other Non-current Liabilities | $17M | $15M | $4M | $20M | $15M | $0 | · | · | · | · | |
| Total Liabilities | $1.66B | $841M | $523M | $408M | $357M | $372M | $368M | $106M | $154M | $100M | |
| Long-term Debt | $1.04B | $435M | $278M | $204M | $184M | $241M | $232M | $0 | · | · | |
| Total Debt | $1.04B | $435M | $278M | · | $184M | $241M | $242M | · | · | · | |
| Common Stock | $49.0K | $48.0K | $47.0K | $47.0K | $45.0K | $42.0K | $36.0K | $34.6K | $32.3K | $25.1K | |
| Paid-in Capital | $471M | $426M | $371M | $360M | $311M | $261M | $160M | $163M | $158M | $88M | |
| Retained Earnings | $308M | $286M | $243M | $182M | $137M | $70M | $32M | $18M | $2M | $-773.3K | |
| Stockholders' Equity | $779M | $713M | $614M | $543M | $448M | $331M | $192M | $181M | $160M | $87M | |
| Liabilities + Equity | $2.22B | $1.35B | $933M | $966M | $867M | $817M | $729M | $513M | $491M | $350M | |
| Shares Outstanding | 48,885,358 | 47,929,872 | · | 46,575,699 | 44,630,873 | 42,249,137 | 35,908,057 | 34,578,040 | 32,304,876 | 25,067,953 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $46M | $28M | $18M | $18M | $18M | $18M | $18M | $19M | $19M | $18M | |
| Stock-based Comp | $39M | $35M | $22M | $16M | $7M | $3M | $2M | $1M | $3M | · | |
| Deferred Tax | $-4M | $-4M | $-12M | $-14M | $8M | $396.0K | $-7M | $-8M | $-21M | $-3M | |
| Amort. of Intangibles | $41M | $26M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | · | |
| Other Non-cash | $12M | $-49M | $-20M | $18M | $-22M | $-7M | $-14M | $4M | $28M | · | |
| Operating Cash Flow | $115M | $52M | $68M | $82M | $70M | $46M | $14M | $25M | $52M | $22M | |
| CapEx | $10M | $8M | $29M | $23M | $19M | $1M | $1M | $1M | $2M | $3M | |
| Investing Cash Flow | $-539M | $-192M | $-66M | $-7M | $17M | $95M | $-181M | $-25M | $27M | $-9M | |
| Debt Issued | · | · | · | · | · | · | $250M | $8M | $5M | · | |
| Net Debt Issued | · | · | · | · | · | $0 | $248M | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $40M | $0 | $0 | $200.0K | $2M | $11M | |
| Stock Repurchased | $26M | $900.0K | $10M | $9M | $6M | $537.0K | $8M | $5M | $3M | $517.5K | |
| Net Stock Activity | $-26M | $-900.0K | $-10M | $-9M | $34M | $-537.0K | $-7M | $-5M | $-1M | · | |
| Dividends Paid | $8M | $4M | $62M | $14M | $31M | $51M | $62M | $18M | $10M | $27M | |
| Financing Cash Flow | $569M | $135M | $3M | $-20M | $-48M | $-52M | $163M | $-11M | $-15M | $-17M | |
| Net Change in Cash | $145M | $-5M | $6M | $55M | $39M | $90M | $-4M | $-11M | $64M | $-4M | |
| Free Cash Flow | $104M | $44M | $40M | $59M | $51M | $45M | $13M | $24M | $50M | · | |
| Levered FCF | · | · | $29M | $55M | $48M | $38M | $9M | $24M | $50M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.8% | · | |
| Net Margin | 0.71% | 2.1% | 4.4% | 4.0% | 9.5% | 5.5% | 2.5% | 2.1% | 7.2% | · | |
| Pretax Margin | 1.2% | 4.0% | 6.5% | 7.6% | 10.1% | 26.0% | 4.6% | 15.9% | 13.9% | · | |
| EBITDA Margin | 3.9% | 5.8% | 7.4% | 10.7% | 14.9% | 14.4% | 9.1% | 20.7% | 15.2% | · | |
| ROA | 1.3% | 3.8% | 6.4% | · | 8.6% | 4.9% | 2.3% | 2.2% | 10.1% | · | |
| ROE | 3.0% | 6.5% | 10.5% | · | 16.6% | 14.5% | 7.6% | 6.4% | 32.3% | · | |
| ROIC | 2.6% | 4.8% | 6.1% | · | 9.8% | 9.7% | 5.1% | 35.7% | 20.3% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.7 | 2.1 | · | 3.5 | 2.9 | 3.1 | 2.4 | 1.3 | · | |
| Quick Ratio | 1.3 | 0.8 | 1.4 | · | 2.6 | 2.3 | 2.2 | 1.6 | 1.1 | · | |
| Debt / Equity | 1.3 | 0.6 | 0.5 | · | 0.4 | 0.7 | 1.3 | · | · | · | |
| LT Debt / Equity | 1.3 | 0.6 | 0.4 | · | 0.4 | 0.7 | 1.2 | · | · | · | |
| Interest Coverage | · | · | 5.3 | 13.2 | 18.2 | 8.5 | 6.8 | 157.8 | 441.0 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.8 | 1.5 | · | 0.9 | 0.9 | 0.9 | 1.0 | 1.4 | · | |
| Receivables Turnover | 9.8 | · | · | · | 87.6 | 76.1 | 59.8 | 67.8 | 27.9 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.94 | · | · | · | · | · | $5.33 | $5.22 | $4.95 | · | |
| Revenue / Share | $64.45 | $42.41 | $29.54 | $25.09 | $17.05 | $18.35 | $15.40 | $13.71 | $12.48 | · | |
| Cash Flow / Share | $2.32 | $1.09 | $1.45 | $1.80 | $1.55 | $1.23 | $0.38 | $0.67 | $1.81 | · | |
| Cash / Share | $8.79 | · | · | · | · | · | $2.87 | $3.09 | $3.09 | · | |
| EPS (TTM) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 40.6% | 38.0% | 26.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.9% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -48.9% | -30.2% | 30.3% | -34.9% | 50.5% | · | · | · | · | · | |
| EPS CAGR 3Y | -22.6% | -16.0% | 8.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -14.5% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -47.9% | -28.9% | 34.4% | -34.5% | 82.9% | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.8% | -14.4% | 17.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -9.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -31.2% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.18B | $2.03B | $1.39B | $1.14B | $774M | $687M | $561M | $520M | $356M | · | |
| Net Income TTM | $22M | $43M | $61M | $45M | $69M | $38M | $14M | $11M | $26M | · | |
| Market Cap | $1.21B | · | · | · | · | · | $661M | $686M | $775M | · | |
| Enterprise Value | $1.82B | · | · | · | · | · | $683M | · | · | · | |
| P/E | 53.9 | 35.0 | 29.7 | 29.9 | 48.3 | 18.1 | 47.2 | 68.4 | 26.7 | · | |
| P/S | 0.4 | · | · | · | · | · | 1.2 | 1.3 | 2.2 | · | |
| P/B | 1.6 | · | · | · | · | · | 3.5 | 3.8 | 4.8 | · | |
| P / Cash Flow | 10.6 | · | · | · | · | · | 48.3 | 26.9 | 14.9 | · | |
| P / FCF | 11.6 | · | · | · | · | · | 52.3 | 28.2 | 15.6 | · | |
| EV / EBITDA | 14.7 | · | · | · | · | · | 13.3 | · | · | · | |
| EV / FCF | 17.4 | · | · | · | · | · | 54.1 | · | · | · | |
| EV / Revenue | 0.6 | · | · | · | · | · | 1.2 | · | · | · | |
| Dividend Yield | 0.65% | · | · | · | · | · | 9.3% | 2.6% | 1.4% | · | |
| Earnings Yield | 1.8% | 2.9% | 3.4% | 3.4% | 2.1% | 5.5% | 2.1% | 1.5% | 3.8% | · | |
| Payout Ratio | 35.1% | 9.3% | 102.2% | 31.1% | 42.1% | 135.5% | 437.2% | 163.9% | 40.5% | · | |
| Annual Payout | $8M | $4M | $62M | $14M | $31M | $51M | $62M | $18M | $10M | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $973M | $965M | $951M | $956M | $655M | $620M | $665M | $479M | $486M | $404M | $353M | $348M | $348M | $337M | $294M | $317M | |
| SG&A Expense | $54M | $62M | $60M | $62M | $51M | $44M | $42M | $38M | $36M | $39M | $38M | $29M | $24M | $21M | $24M | $21M | |
| Operating Expenses | $938M | $937M | $932M | $937M | $634M | $600M | $664M | $450M | $456M | $374M | $357M | $309M | $321M | $315M | $282M | $267M | |
| Operating Income | $34M | $29M | $18M | $19M | $20M | $21M | $720.0K | $28M | $30M | $30M | $-4M | $39M | $27M | $22M | $13M | $50M | |
| Interest Expense | · | · | · | · | · | · | · | · | $9M | $8M | · | $4M | $4M | $3M | · | $2M | |
| Interest Income | $6M | $4M | $4M | $4M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $1M | $223.0K | |
| Other Non-op | $-2M | $662.0K | $703.0K | $445.0K | $1M | $-5M | $353.0K | $3M | $6M | $-4M | $2M | $2M | $1M | $1M | $2M | $-1M | |
| Pretax Income | $27M | $20M | $8M | $6M | $17M | $10M | $-2M | $27M | $32M | $24M | $923.0K | $38M | $31M | $19M | $10M | $41M | |
| Income Tax | $9M | $7M | $944.0K | $5M | $7M | $3M | $6M | $8M | $10M | $7M | $1M | $10M | $14M | $7M | $11M | $17M | |
| Net Income | $20M | $14M | $6M | $373.0K | $9M | $7M | $-7M | $16M | $19M | $15M | $12M | $22M | $13M | $13M | $-3M | $23M | |
| EPS (Basic) | $0.40 | $0.30 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.34 | $0.40 | $0.31 | $0.27 | $0.47 | $0.28 | $0.28 | $-0.08 | $0.52 | |
| EPS (Diluted) | $0.40 | $0.29 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.33 | $0.40 | $0.31 | $0.26 | $0.47 | $0.28 | $0.28 | $-0.06 | $0.50 | |
| Shares (Basic) | 49,115,835 | 48,853,678 | · | 49,217,134 | 49,187,885 | 48,470,682 | · | 47,686,841 | 47,615,096 | 47,260,351 | · | 46,547,502 | 46,482,271 | 46,555,406 | · | 44,946,725 | |
| Shares (Diluted) | 49,778,028 | 49,054,135 | · | 49,473,417 | 49,470,677 | 48,850,666 | · | 48,223,788 | 47,978,491 | 47,699,537 | · | 46,920,607 | 46,778,299 | 46,954,687 | · | 46,152,536 | |
| EBITDA | $34M | $44M | · | $19M | $20M | $27M | · | $28M | $30M | $35M | · | $39M | $27M | $27M | · | $50M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $401M | $478M | $429M | $462M | $340M | $259M | $288M | $348M | $325M | $335M | $294M | $274M | $294M | $275M | $288M | $184M | |
| Short-term Investments | · | · | · | $1M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | $4M | $4M | · | $33M | |
| Receivables | $465M | $467M | $374M | $381M | $349M | · | $276M | · | · | · | · | · | · | $76M | · | $69M | |
| Prepaid Expense | $26M | $26M | $26M | $23M | $22M | $24M | $25M | $21M | $17M | $17M | · | $14M | $15M | $22M | · | $12M | |
| Current Assets | $919M | $1.00B | $863M | $884M | $729M | $613M | $638M | $597M | $570M | $539M | · | $476M | $465M | $455M | · | $444M | |
| PP&E (Net) | $63M | $60M | $57M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $87M | · | · | · | $39M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $30M | · | · | · | $25M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $887M | $875M | $865M | $863M | $417M | $416M | $419M | $410M | $410M | $410M | $279M | $276M | $274M | $269M | $269M | $257M | |
| Intangibles | $243M | $257M | $271M | $285M | $106M | $112M | $118M | $109M | $116M | $120M | · | $74M | $74M | $78M | · | $73M | |
| Other Non-current Assets | $28M | $27M | $23M | $23M | $30M | $31M | $17M | $9M | $9M | $4M | · | $9M | $7M | $5M | · | $6M | |
| Total Assets | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B | $1.23B | · | $1.07B | $1.03B | $999M | · | $943M | |
| Accounts Payable | $246M | $221M | $196M | $210M | $120M | $106M | $106M | $95M | $96M | $146M | · | $53M | $50M | $49M | · | $25M | |
| Current Liabilities | $748M | $745M | $615M | $630M | $460M | $361M | $366M | $313M | $310M | $355M | · | $203M | $186M | $173M | · | $156M | |
| Capital Leases | $34M | $30M | $32M | $30M | $29M | $29M | $31M | $31M | $27M | $38M | · | $21M | $18M | $18M | · | $16M | |
| Deferred Tax | $9M | $7M | $5M | $4M | $3M | $4M | $5M | $3M | $3M | $4M | · | $12M | $12M | $14M | · | $5M | |
| Other Non-current Liabilities | $10M | $19M | $17M | $16M | $12M | $15M | $15M | $7M | $8M | $8M | · | $14M | $21M | $22M | · | $13M | |
| Total Liabilities | $1.68B | $1.78B | $1.66B | $1.68B | $904M | $814M | $841M | $778M | $774M | $774M | · | $458M | $444M | $434M | · | $390M | |
| Long-term Debt | $936M | $1.03B | $1.04B | $1.05B | $414M | $416M | $435M | $438M | $442M | $389M | · | $209M | $208M | $206M | · | $202M | |
| Total Debt | $936M | $1.03B | · | $1.05B | $414M | $416M | · | $438M | $442M | $389M | · | $209M | $208M | $206M | · | $202M | |
| Common Stock | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | · | $47.0K | $47.0K | $47.0K | · | $45.0K | |
| Paid-in Capital | $488M | $478M | $471M | $473M | $463M | $452M | $426M | $411M | $402M | $395M | · | $363M | $357M | $353M | · | $315M | |
| Retained Earnings | $342M | $323M | $308M | $302M | $302M | $293M | $286M | $293M | $277M | $258M | · | $231M | $209M | $196M | · | $195M | |
| Stockholders' Equity | $830M | $800M | $779M | $776M | $765M | $745M | $713M | $705M | $679M | $653M | · | $594M | $566M | $548M | · | $510M | |
| Liabilities + Equity | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B | $1.23B | · | $1.07B | $1.03B | $999M | · | $943M | |
| Shares Outstanding | · | · | 48,885,358 | · | · | · | 47,929,872 | · | · | · | · | 46,607,356 | 46,553,517 | 46,488,443 | · | 44,884,522 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $16M | $16M | $7M | $7M | $8M | $7M | $7M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | |
| Stock-based Comp | $12M | $10M | $11M | $8M | $12M | $8M | $15M | $6M | $7M | $6M | $9M | $6M | $4M | $3M | $6M | $4M | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $6M | $6M | $5M | $7M | $7M | $7M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | · | $28M | · | · | · | $-5M | · | · | · | $-20M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $33M | $68M | $-3M | $10M | $91M | $17M | $-11M | $34M | $23M | $6M | $19M | $15M | $26M | $8M | $85M | $-36M | |
| CapEx | $4M | $4M | $3M | $3M | $1M | $3M | $3M | $2M | $3M | $369.0K | $7M | $4M | $11M | $6M | $886.0K | $3M | |
| Investing Cash Flow | $-6M | $-3M | $-1M | $-534M | $-1M | $-2M | $-33M | $-8M | $-80M | $-71M | $-11M | $-35M | $-5M | $-14M | $13M | $-8M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-153.0K | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $0 | $3M | $15M | $0 | $0 | $11M | $900.0K | $0 | · | · | · | $150.0K | $10M | $0 | · | $168.0K | |
| Net Stock Activity | · | $-3M | · | · | · | $-11M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $95.0K | $104.0K | $2M | $96.0K | $778.0K | $5M | $2M | $218.0K | $2M | $95.0K | $60M | $1M | $722.0K | $120.0K | $1M | $120.0K | |
| Financing Cash Flow | $-104M | $-16M | $-26M | $648M | $-9M | $-44M | $-15M | $-3M | $47M | $106M | $12M | $-510.0K | $-963.0K | $-7M | $6M | $-6M | |
| Net Change in Cash | $-78M | $49M | $-30M | $124M | $81M | $-30M | $-60M | $23M | $-9M | $41M | $20M | $-20M | $20M | $-13M | $104M | $-50M | |
| Taxes Paid | $11M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $64M | · | · | · | $14M | · | · | · | $6M | · | · | · | $2M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $279.8K | · | · | · | $-410.3K | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 3.0% | · | 2.0% | 3.1% | 3.3% | · | 5.9% | 6.2% | 7.4% | · | 11.2% | 7.8% | 6.6% | · | 15.8% | |
| Net Margin | 2.0% | 1.5% | · | 0.04% | 1.4% | 1.1% | · | 3.4% | 3.9% | 3.7% | · | 6.3% | 3.8% | 3.9% | · | 8.2% | |
| Pretax Margin | 2.8% | 2.0% | · | 0.59% | 2.6% | 1.6% | · | 5.6% | 6.6% | 5.9% | · | 10.9% | 9.0% | 5.8% | · | 13.0% | |
| EBITDA Margin | 3.5% | 4.6% | · | 2.0% | 3.1% | 4.4% | · | 5.9% | 6.2% | 8.7% | · | 11.2% | 7.8% | 7.9% | · | 15.8% | |
| ROA | 1.1% | 0.78% | · | 0.02% | 0.70% | 0.52% | · | 1.4% | 1.7% | 1.3% | · | 2.2% | 1.3% | 1.4% | · | 2.9% | |
| ROE | 2.5% | 1.9% | · | 0.05% | 1.3% | 0.96% | · | 2.5% | 3.1% | 2.5% | · | 4.0% | 2.5% | 2.6% | · | 5.5% | |
| ROIC | 1.3% | 1.0% | · | 0.20% | 1.1% | 1.1% | · | 1.8% | 1.8% | 2.0% | · | 3.6% | 1.9% | 1.9% | · | 4.7% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | · | 1.4 | 1.6 | 1.7 | · | 1.9 | 1.8 | 1.5 | · | 2.3 | 2.5 | 2.6 | · | 2.8 | |
| Quick Ratio | 1.2 | 1.3 | · | 1.3 | 1.5 | 0.7 | · | 1.1 | 1.1 | 0.9 | · | 1.4 | 1.6 | 2.0 | · | 1.8 | |
| Debt / Equity | 1.1 | 1.3 | · | 1.4 | 0.5 | 0.6 | · | 0.6 | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 1.1 | 1.2 | · | 1.3 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 3.5 | 4.0 | · | 10.3 | 7.4 | 6.8 | · | 20.7 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 3.6 | · | 4.2 | 3.1 | · | · | · | · | · | · | · | · | 5.1 | · | 7.2 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | $12.74 | $12.16 | $11.79 | · | $11.37 | |
| Revenue / Share | $19.54 | $19.67 | · | $19.32 | $13.24 | $12.70 | · | $9.93 | $10.14 | $8.48 | · | $7.42 | $7.44 | $7.18 | · | $6.87 | |
| Cash Flow / Share | · | $1.39 | · | · | · | $0.34 | · | · | · | $0.13 | · | · | · | $0.16 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | $5.88 | $6.31 | $5.91 | · | $4.10 | |
| EPS (TTM) | $0.82 | $0.61 | · | $0.20 | $0.52 | $0.73 | · | $1.30 | $1.44 | $1.32 | · | $0.97 | $1.00 | $0.98 | · | $1.26 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.84B | $3.53B | · | $2.90B | $2.42B | $2.25B | · | $1.72B | $1.59B | $1.45B | · | $1.33B | $1.30B | $1.22B | · | $1.05B | |
| Net Income TTM | $41M | $30M | · | $10M | $25M | $35M | · | $62M | $68M | $62M | · | $45M | $46M | $45M | · | $58M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | $1.44B | $1.47B | $1.70B | · | $1.75B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $1.37B | $1.38B | $1.62B | · | $1.74B | |
| P/E | 56.6 | 40.2 | · | 141.8 | 47.8 | 42.5 | · | 44.6 | 28.2 | 31.8 | · | 31.8 | 31.6 | 37.2 | · | 31.0 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 1.1 | 1.1 | 1.4 | · | 1.7 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | 2.4 | 2.6 | 3.1 | · | 3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 5.9 | 6.8 | 8.4 | · | 9.7 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | 219.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1.0 | 1.1 | 1.3 | · | 1.7 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.25% | 0.16% | 0.77% | · | 0.72% | |
| Earnings Yield | 1.8% | 2.5% | · | 0.71% | 2.1% | 2.4% | · | 2.2% | 3.5% | 3.1% | · | 3.1% | 3.2% | 2.7% | · | 3.2% | |
| Payout Ratio | · | 0.72% | · | · | · | 81.5% | · | · | · | 0.64% | · | · | · | 0.91% | · | · | |
| Annual Payout | $2M | $3M | · | $8M | $8M | $9M | · | $62M | $63M | $62M | · | $4M | $2M | $13M | · | $13M |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| 收入 | $3.18B | $2.03B | $1.39B | $1.14B | · |
| 营业利润率 % | 2.5% | 4.4% | 6.1% | 9.1% | · |
| 净收入 | $22M | $43M | $61M | $45M | · |
| 稀释后每股收益 (EPS) | $0.46 | $0.90 | $1.29 | $0.99 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 1.3 | 0.6 | 0.5 | · | · |
| 流动比率 | 1.4 | 1.7 | 2.1 | · | · |
| 速动比率 | 1.3 | 0.8 | 1.4 | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| 自由现金流 | $104M | $44M | $40M | $59M | · |
机构持有人 (13F) 227 家申报者 · $1.6B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
227
持有价值
$1.6B
新仓位
55
已退出持仓
16
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 55 (+22 与上一季度对比) | 16 (-9 与上一季度对比) | 80 (+16 与上一季度对比) | 51 (0 与上一季度对比) | +2.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $320228534 | 6899990 | 20.25% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $120934018 | 2605775 | 7.65% | 股份 |
| VANGUARD GROUP INC | $105149543 | 4238192 | 6.65% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $90333863 | 1946431 | 5.71% | 股份 |
| STATE STREET CORP | $80703741 | 1738930 | 5.10% | 股份 |
| 325 CAPITAL LLC | $74898454 | 1613843 | 4.74% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $68147789 | 1468508 | 4.31% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $59988313 | 1292573 | 3.79% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $54215672 | 1167974 | 3.43% | 股份 |
| BANK OF AMERICA CORP /DE/ | $39548050 | 852145 | 2.50% | 股份 |
| FMR LLC | $31833629 | 685922 | 2.01% | 股份 |
| WELLS FARGO & COMPANY/MN | $30859865 | 664940 | 1.95% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30290368 | 652669 | 1.92% | 股份 |
| AMERIPRISE FINANCIAL INC | $23767026 | 512110 | 1.50% | 股份 |
| NORTHERN TRUST CORP | $23439092 | 505044 | 1.48% | 股份 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $22088422 | 475941 | 1.40% | 股份 |
| ROYCE & ASSOCIATES LP | $21927797 | 472480 | 1.39% | 股份 |
| SteelPeak Wealth, LLC | $21577727 | 464937 | 1.36% | 股份 |
| MORGAN STANLEY | $20119143 | 433508 | 1.27% | 股份 |
| Invesco Ltd. | $17720731 | 381830 | 1.12% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $14248891 | 307022 | 0.90% | 股份 |
| GOLDMAN SACHS GROUP INC | $12614145 | 271798 | 0.80% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $12424235 | 267706 | 0.79% | 股份 |
| EARNEST PARTNERS LLC | $12019772 | 258991 | 0.76% | 股份 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $11575118 | 249410 | 0.73% | 股份 |
| Bank of New York Mellon Corp | $10901538 | 234896 | 0.69% | 股份 |
| LPL Financial LLC | $10288911 | 221696 | 0.65% | 股份 |
| 683 Capital Management, LLC | $9746101 | 210000 | 0.62% | 股份 |
| UBS Group AG | $8908678 | 191956 | 0.56% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $8841244 | 190503 | 0.56% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $8700111 | 187462 | 0.55% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $8581255 | 184901 | 0.54% | 股份 |
| Public Sector Pension Investment Board | $8342012 | 179746 | 0.53% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $7162316 | 154327 | 0.45% | 股份 |
| 1492 Capital Management LLC | $6773354 | 145946 | 0.43% | 股份 |
| Empowered Funds, LLC | $6301503 | 135779 | 0.40% | 股份 |
| Nuveen, LLC | $6164269 | 132822 | 0.39% | 股份 |
| AXA Investment Managers S.A. | $5882030 | 207479 | 0.37% | 股份 |
| SEI INVESTMENTS CO | $5718354 | 123214 | 0.36% | 股份 |
| TOWLE & CO | $5702072 | 122863 | 0.36% | 股份 |
| Rhenman & Partners Asset Management AB | $5517592 | 118888 | 0.35% | 股份 |
| Emerald Investment Advisers, LLC | $5339238 | 115045 | 0.34% | 股份 |
| RHUMBLINE ADVISERS | $4970861 | 107108 | 0.31% | 股份 |
| Legal & General Group Plc | $4555234 | 98152 | 0.29% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $4547902 | 97994 | 0.29% | 股份 |
| Swiss National Bank | $4151096 | 89444 | 0.26% | 股份 |
| Westmount Partners, LLC | $3608610 | 77755 | 0.23% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3542847 | 76338 | 0.22% | 股份 |
| Insight Wealth Strategies, LLC | $3513495 | 143291 | 0.22% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $3464321 | 74646 | 0.22% | 股份 |
激进投资者及 5%+ 股东 11 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Allied Physicians of California, a Professional Medical Corporation ×9 申报 | 2025年2月18日 | 11.00% | 修订 | 资本结构 | SEC |
| Kenneth T. Sim ×4 申报 | 2020年2月24日 | · | 初始申报 | · | SEC |
| Thomas S. Lam ×4 申报 | 2020年2月24日 | · | 初始申报 | · | SEC |
| Lakhi Sakhrani ×4 申报 | 2020年2月24日 | · | 初始申报 | · | SEC |
| 2019年9月16日 | · | 初始申报 | · | SEC | |
| Adrian Vazquez, M.D. ×2 申报 | 2017年12月19日 | · | 初始申报 | 并购/出售 | SEC |
| Warren Hosseinion, M.D. ×2 申报 | 2017年12月15日 | · | 初始申报 | 并购/出售 | SEC |
| NNA OF NEVADA, INC., FRESENIUS MEDICAL CARE HOLDINGS, INC., FRESENIUS MEDICAL CARE AG & CO. KGaA ×3 申报 | 2017年12月13日 | · | 初始申报 | · | SEC |
| Network Medical Management, Inc. ×3 申报 | 2017年12月12日 | · | 初始申报 | · | SEC |
| Warren Hosseinion | 2008年6月25日 | · | 初始申报 | · | SEC |
| Adrian Vazquez | 2008年6月25日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 32 位内幕人士 · 12 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Brandon Sim | CEO and President | 2026年9月5日 F | 1238861 | 0 | 0 | $0 |
| Warren Hosseinion | Co-Chief Executive Officer | 2018年11月28日 S | 524438 | 0 | 0 | $0 |
| Chandan Basho | COO and CFO | 2026年9月5日 F | 157820 | 0 | 0 | $0 |
| Mihir Shah | Chief Financial Officer | 2018年1月15日 M | 19932 | 0 | 0 | $0 |
| Mitchell Creem | Chief Financial Officer | 2015年3月31日 A | · | 0 | 0 | $0 |
| Kyle Francis | EVP and CFO | 2013年8月22日 A | 2100000 | 0 | 0 | $0 |
| Hing Ang | Chief Operating Officer | 2020年5月26日 D | 38316 | 0 | 0 | $0 |
| John Vong | SVP - Accounting (PAO) | 2026年9月15日 F | 22330 | 0 | 0 | $0 |
| Kenneth T. Sim | Executive Chairman | 2026年4月6日 A | 739407 | 0 | 0 | $0 |
| Dinesh M. Kumar | Chief Medical Officer | 2026年4月1日 F | 177655 | 0 | 0 | $0 |
| Adrian Vazquez | Chief Medical Officer | 2021年4月28日 S | 371004 | 0 | 0 | $0 |
| Mark Meyers | Chief Strategy Officer | 2013年10月22日 A | · | 0 | 0 | $0 |
| Mitchell W Kitayama | 董事 | 2026年8月31日 D | 24337 | 0 | 0 | $0 |
| David Schmidt | 董事 | 2026年8月14日 M | 36019 | 0 | 0 | $0 |
| Matthew Mazdyasni | 董事 | 2026年6月10日 A | 39288 | 0 | 0 | $0 |
| John Chiang | 董事 | 2026年6月10日 A | 35373 | 0 | 0 | $0 |
| Linda Dong | 董事 | 2026年6月10日 A | 97133 | 0 | 0 | $0 |
| Weili Dai, | 董事 | 2026年6月10日 A | 18188 | 0 | 0 | $0 |
| Thomas S. Lam | 董事 | 2026年4月6日 A | 465657 | 0 | 0 | $0 |
| Gary Augusta | 董事 | 2018年8月17日 S | 152997 | 0 | 0 | $0 |
| Edward Schreck | 董事 | 2016年9月14日 A | · | 0 | 0 | $0 |
| Suresh Nihalani | 董事 | 2016年9月14日 A | 800000 | 0 | 0 | $0 |
| Allied Physicians of California, a Professional Medical Corporation | 10% 所有者 | 2025年2月15日 J | 6132802 | 0 | 0 | $0 |
| Bradley S Shepherd | 10% 所有者 | 2005年5月20日 S | 10200000 | 0 | 0 | $0 |
| Glenn Sobotka | · | 2026年8月7日 D | 2246 | 0 | 0 | $0 |
| Albert Waichow Young | · | 2022年12月2日 J | 1184749 | 0 | 0 | $0 |
| Eric Chin | · | 2022年3月31日 F | 20844 | 0 | 0 | $0 |
| Michael F. Eng | · | 2022年1月20日 A | 4890 | 0 | 0 | $0 |
| Mark Fawcett | · | 2022年1月20日 A | 30000 | 0 | 0 | $0 |
| BATES ERNEST A | · | 2022年1月20日 A | · | 0 | 0 | $0 |
| Li Yu | · | 2020年11月11日 A | · | 0 | 0 | $0 |
| Network Medical Management, Inc. | · | 2017年12月8日 J | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 46 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| RZV · Invesco Exchange-Traded Fund Trust | 0.93% | 73829 SH | 2026年10月2日 | 每日 |
| PSCH · Invesco Exchange-Traded Fund Trus... | 0.80% | 39995 SH | 2026年10月2日 | 每日 |
| QIDX · Spinnaker ETF Series | 0.31% | 3368 NS | 2026年7月31日 | N-PORT |
| IHF · iShares Trust | 0.24% | 81583 SH | 2026年9月11日 | 每日 |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.23% | 128133 SH | 2026年10月2日 | 每日 |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.21% | 90075 SH | 2026年8月19日 | 每日 |
| EBIT · Harbor ETF Trust | 0.19% | 624 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.12% | 48925 SH | 2026年8月19日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.12% | 19716 NS | 2026年7月31日 | N-PORT |
| IWO · iShares Trust | 0.11% | 428254 SH | 2026年9月11日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.11% | 147980 SH | 2026年8月19日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.10% | 6438 SH | 2026年10月2日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 63102 SH | 2026年10月2日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.06% | 591784 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 262660 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.06% | 1164990 SH | 2026年9月11日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.05% | 10366 NS | 2026年7月31日 | N-PORT |
| RSSL · Global X Funds | 0.05% | 21812 NS | 2026年7月31日 | N-PORT |
| ESML · iShares Trust | 0.05% | 37908 SH | 2026年9月11日 | 每日 |
| SMDX · Tidal Trust III | 0.05% | 1882 NS | 2026年7月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.05% | 117567 NS | 2026年7月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.05% | 18796 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.05% | 12335 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.04% | 183061 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.03% | 134131 SH | 2026年8月19日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.03% | 108048 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 21507 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.02% | 3190 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 487188 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.02% | 1022756 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.02% | 2757 SH | 2026年9月11日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.01% | 124687 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 4223 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 6176 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3078 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 13356 NS | 2026年7月31日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 10954 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 12752 SH | 2026年9月3日 | 每日 |
| ITOT · iShares Trust | 0.00% | 56129 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 12032 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1417307 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3772 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 2590268 SH | 2026年9月10日 | 每日 |
| IJS · iShares Trust | · | 378419 SH | 2026年9月8日 | 每日 |
| XJR · iShares Trust | · | 5875 SH | 2026年8月31日 | 每日 |
| ISCB · iShares Trust | · | 1764 SH | 2026年9月11日 | 每日 |
ASTH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 16 位分析师
买入
中位数目标
$53.00
+47.7%
6 37.5%
强烈买入
8 50.0%
买入
2 12.5%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-09-20平均目标 $51.67 +44.0%
← 低于所有目标
当前价格 $35.88
最低$41.00
平均值$51.67
最高$65.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | · |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | · |
| ADUS | · | 20.6 | 23.2% | · | · | · |
| WGS | · | · | · | · | · | · |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| AGL | $7.14B | · | -2.1% | -6.6% | -146.1% | · |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | · |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $1.61B | -592.5 | 15.9% | -0.26% | -1.1% | 23.0% |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报